Document is current
Any future updates will be listed below
-
Authors
Karlsen, Tom H. http://orcid.org/0000-0002-8289-9931
- License Information
-
More Information
Article History
First Online: 11 April 2022
Competing interests
: The author declares speaker fees from AlfaSigma and Gilead and consultancy fees from Novartis and Intercept. The author has received research grants from Canica A/S.
Free to read: This content has been made available to all.
